diphenyliodonium has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, JR; Grünheck, F; Hescheler, J; Hoffmann, E; Petros, J; Sauer, H; Schwindt, H; Wartenberg, M | 1 |
1 other study(ies) available for diphenyliodonium and Prostatic Neoplasms
Article | Year |
---|---|
Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids.
Topics: Ascorbic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Line, Tumor; Drug Resistance, Multiple; Free Radical Scavengers; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Multidrug Resistance-Associated Proteins; NADPH Oxidase 1; NADPH Oxidases; Onium Compounds; Prostatic Neoplasms; Reactive Oxygen Species; Spheroids, Cellular; Sulfones; Transcription Factors; Vitamin E | 2005 |